A new class of anti-HIV therapy and new challenges.
Dolin
Raphael
R
D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D065100:CCR5 Receptor Antagonists; D003510:Cyclohexanes / Q000627:therapeutic use*; D024882:Drug Resistance, Viral; D023581:HIV Fusion Inhibitors / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D000077592:Maraviroc; D014230:Triazoles / Q000627:therapeutic use*
D044966:Anti-Retroviral Agents; D065100:CCR5 Receptor Antagonists; D003510:Cyclohexanes; D023581:HIV Fusion Inhibitors; D014230:Triazoles; D000077592:Maraviroc